1. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 1995; 31B: 86-99.
2. Takata T, Slootweg PJ. Odontogenic and Maxillofacial bone tumours. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ eds. WHO Classification of head and Neck Tumours. Lyon: IARC, 2017, 203-60.
3. McClary AC, West RB, McClary AC, et al. Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol 2016; 273: 1649-61.
4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
5. Yoshihama R, Yamaguchi K, Imajyo I, et al. Expression levels of SOX2, KLF4 and brachyury transcription factors are associated with metastasis and poor prognosis in oral squamous cell carcinoma. Oncol Lett 2016; 11: 1435-46.
6. Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development 2009; 136: 2311-22.
7. Sholl LM, Barletta JA, Yeap BY, Chirieac LR, Hornick JL. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol 2010; 34: 1193-8.
8. Juuri E, Isaksson S, Jussila M, Heikinheimo K, Thesleff I. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium. Eur J Oral Sci 2013; 121: 509-16.
9. Evans PM, Liu C. Roles of Krüppel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin 2008; 40: 554-64.
10. Patel NV, Ghaleb AM, Nandan MO, Yang VW. Expression of the tumor suppressor Krüppel-like factor 4 as a prognostic predictor for colon cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 2631-8.
11. Hsu LS, Chan CP, Chen CJ, et al. Decreased Krüppel-like factor 4 (KLF4) expression may correlate with poor survival in gastric adenocarcinoma. Med Oncol 2013; 30: 632.
12. Kumamoto H, Kinouchi Y, Ooya K. Telomerase activity and telomerase reverse transciptase (TERT) expression in ameloblastomas. J Oral Pathol Med 2001; 30: 231-6.
13. Kumamoto H, Ohki K. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors. J Oral Pathol Med 2010; 39: 87-93.
14. Monroy EAC, Santos PPA, Lopes MLDS, Taylor AM, Pinto LP, Souza LB. Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions. Histochem Cell Biol 2018; 150:371-7.
15. Chacham M, Almoznino G, Hurvitz AZ, Buchner A, Vered M. Expression of stem cell makers in stroma of odontogenic cysts and tumors. J Oral Pathol Med 2020; 49: 1067-77.
16. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cell, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
17. Slack JM. Origin of Stem cells in organogenesis. Science 2008; 322: 1498-501.
18. Peng Z, Liu L, Wei X, Ling J. Expression of Oct-4, Sox-2, and MYC in dental papilla cells and dental follicle cells during in-vivo tooth development and in-vitro co-culture. Eur J Oral Sci 2014; 122: 251-8.
19. Chen Z, Couble ML, Mouterfi N, Magloire H, Chen Z, Bleicher F. Spatial and temporal expression of KLF4 and KLF5 during murine tooth development. Arch Oral Biol 2009; 54: 403-11.
20. Lee HK, Lee DS, Park SJ, Cho KH, Bae HS, Park JC. Nuclear factor I-C (NFIC) regulates dentin sialophosphoprotein (DSPP) and E- cadherin via control of Krüppel-like factor 4 (KLF4) during dentinogenesis. J Biol Chem 2014; 289: 28225-36.
21. Hussenet T, Dali S, Exinger J, et al. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 2010; 5: e8960.
22. Neumann J, Bahr F, Horst D, et al. SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 2011; 11: 518.
23. Abdel AA, Amin MM. EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence. Diagn Pathol 2012; 10: 1596-14.
24. Ahlem B, Wided A, Amani L, Nadia Z, Amira A, Faten F. Study of Ki67 and CD10 expression predictive factors of recurrence of ameloblastoma. Science Direct 2015; 132: 275-9.